Curemark Revenue and Competitors
Estimated Revenue & Valuation
- Curemark's estimated annual revenue is currently $4.2M per year.
- Curemark's estimated revenue per employee is $155,000
Employee Data
- Curemark has 27 Employees.
- Curemark grew their employee count by 13% last year.
Curemark's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Staff at Curemark | Reveal Email/Phone |
2 | VP Finance | Reveal Email/Phone |
3 | VP Manufacturing Sciences and Technology | Reveal Email/Phone |
4 | SVP, Corporate Strategy & Finance | Reveal Email/Phone |
5 | Director Clincal Operations | Reveal Email/Phone |
6 | Senior Director Operations | Reveal Email/Phone |
7 | Medical Director | Reveal Email/Phone |
Curemark Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Curemark?
Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson's disease.
keywords:N/AN/A
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Curemark News
2022-04-17 - How being more flexible can benefit your life, career
Joan Fallon is the founder and CEO of Curemark, and is considered a visionary scientist who has dedicated her life's work to championing the...
2022-04-13 - Autism Spectrum Disorder Diagnostics Market Size, Scope ...
Autism Spectrum Disorder Diagnostics Market Size, Scope And Forecast | Leading Players Pfizer, Merck, Roche, SynapDx, Curemark.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 30 | 7% | N/A |
#2 | $5.5M | 31 | 0% | N/A |
#3 | $5.2M | 32 | 0% | N/A |
#4 | $4.1M | 32 | 23% | N/A |
#5 | $7M | 35 | -8% | N/A |